C-Reactive Protein/Albumin Ratio (CAR) as a Prognostic Factor in Patients with Non-Metastatic Nasopharyngeal Carcinoma
Shasha He, Yan Wang, Haiyang Chen, Lin Yang, Shaobo Liang, Lixia Lu, Yong Chen · Journal of Cancer · 2016
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2016
Abstract
Background: The C-reactive protein/albumin (CRP/ALB) ratio has recently been associated with clinical outcomes in patients suffering various types of cancer.In this retrospective study, we investigated the prognostic value of the pre-treatment CRP/ALB ratio (CAR) in non-metastatic nasopharyngeal carcinoma (NPC) patients.Methods: The cohort included 2685 patients with non-metastatic NPC.Univariate and multivariate COX proportional hazards analyses were applied to evaluate the associations of CAR with overall survival (OS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and locoregional recurrence-free survival (LRRFS) in patients with NPC.Kaplan-Meier survival analyses was used to compare groups classified by CAR.Results: Patients were categorised by the CAR using a cut-off value of 0.064.Multivariate Cox proportional hazard analysis verified that high CAR level was a significant predictor for inferior OS (P = 0.003), DMFS (P = 0.035), and LRRFS (P = 0.024), but not for DFS (P = 0.093).CAR was also an independent prognostic factor for OS when stratified by Epstein-Barr virus DNA level ( ≥ 2560 or < 2560 copies ml -1 ).Conclusions: High CAR provides prognostication regarding OS, DMFS, DFS, and LRRFS in patients with NPC.CAR is a valuable coadjutant for Epstein-Barr virus DNA levels for identifying survival differences.
Open the resolved locator · 10.7150/jca.16443
Metadata licence: OpenAlex metadata (CC0)